Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin
Baptist Gallwitz Department of Medicine IV, Eberhard-Karls University, Tübingen, Germany Abstract: Dipeptidyl-peptidase-IV (DPP-4) inhibitors are oral antidiabetic agents that can be administered as monotherapy in patients with contraindications to metformin or metformin intolerance, and...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-05-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/management-of-patients-with-type-2-diabetes-and-mildmoderate-renal-imp-peer-reviewed-article-TCRM |